StockData
Zai Lab Ltd logo

Zai Lab Ltd (ZLAB) stock

ZLABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30471% above fair value
$24.60−1.44 (-5.53%)

Close on Nov 13, 2026Market cap $3.82BP/E –Yield –

Zai Lab gross margin

Gross margin is gross profit as a percentage of revenue.

Zai Lab's gross margin for the twelve months ending Sep 30, 2026 was 54.7%. For fiscal 2025 it was 58.6%, against 63.1% the year before. The highest annual figure on record is 71.1% in fiscal 2019.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202558.6%−4.5
FY2024Dec 31, 202463.1%−0.9
FY2023Dec 31, 202364.1%−1.5
FY2022Dec 31, 202265.6%+1.8
FY2021Dec 31, 202163.8%−2.0
FY2020Dec 31, 202065.8%−5.3
FY2019Dec 31, 201971.1%+4.6
FY2018Dec 31, 201866.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 202652.6%−7.1
Q2 FY2026Jun 30, 202654.7%−6.2
Q1 FY2026Mar 31, 202661.5%−2.4
Q4 FY2025Dec 31, 202551.2%−10.5
Q3 FY2025Sep 30, 202559.7%−4.5
Q2 FY2025Jun 30, 202560.9%−4.1
Q1 FY2025Mar 31, 202563.9%+2.5
Q4 FY2024Dec 31, 202461.7%+0.0
Q3 FY2024Sep 30, 202464.2%+1.0
Q2 FY2024Jun 30, 202465.0%−0.5
Q1 FY2024Mar 31, 202461.4%−4.6
Q4 FY2023Dec 31, 202361.7%−4.9
Q3 FY2023Sep 30, 202363.2%−2.0
Q2 FY2023Jun 30, 202365.5%+1.6
Q1 FY2023Mar 31, 202366.0%−0.5
Q4 FY2022Dec 31, 202266.6%+15.9
Q3 FY2022Sep 30, 202265.2%−6.6
Q2 FY2022Jun 30, 202263.9%−6.7
Q1 FY2022Mar 31, 202266.5%+3.9
Q4 FY2021Dec 31, 202150.6%−4.2
Q3 FY2021Sep 30, 202171.8%+5.5
Q2 FY2021Jun 30, 202170.6%−3.1
Q1 FY2021Mar 31, 202162.7%−12.0
Q4 FY2020Dec 31, 202054.8%−11.3
Q3 FY2020Sep 30, 202066.3%−7.4
Q2 FY2020Jun 30, 202073.7%–
Q1 FY2020Mar 31, 202074.6%–
Q4 FY2019Dec 31, 201966.1%–
Q3 FY2019Sep 30, 201973.7%–

More Zai Lab figures

See a number that looks wrong?